An Exciting Start 1971 - 1981
- Late Dr. Vinod Daftary opens a blood bank.
- An injection that helps RH-blood group women become mothers is launched.
- Took our expertise one step ahead by exporting polyclonal sera.
- Commissioned a plant in Thane.
- Launched indigenously developed Plasma Fractions
R&D Takes Centre Stage 1981 - 2000
- R&D recognition from Dept. of Scientific & Industrial Research, Govt. of India.
- Launched India's first immunoglobulin against pseudomonas infection.
Global Footprint 2001 - 2011
- EU & US FDA approved facility in Germany.
- Started Operations in the Philippines-as a wholly owned subsidiary
- Manufacturing facility at Ambernath near Mumbai opens.
- Patent filing started - we have 15 product patents in India & globally.
- Launched recombinant hormone for stimulating ovarian follicular growth to tackle infertility issues.
On a Fast-Track 2012 - 2016
- Frost and Sullivan acknowledges BSV as the fastest-growing biotech company.
- Launched a cure for sepsis and acute pancreatitis.
- 62 products in the domestic market, 32 globally.
- ISO 45001:2018 (Occupational Health & Safety Management System).
- ISO 14001:2015 (Environment Management System).
- Ranked amongst Top 10 biopharmaceutical companies by Biospectrum.
- Anti-RhD global patent granted.
- Launched Recombinant Anti-D
Setting Benchmarks in Healthcare 2017 - 2020
- Advent International buys majority stake.
- Strategic acquisition of Malaysian entity to solidify our position and expertise in the IVF segment.
- Launched GTM initiatives in 17 countries with a dedicated field force on ground, significantly expanding our global market presence.
- Ambernath plant gains approval from EU GMP from Halmed & Brazil ANVISA.
- ISO 9001:2015 (Quality Management System).
Creating a Sustainable, Future-ready healthcare 2021 - Now
- BSV acquires TTK Healthcare's Human Pharma business.
- Grew our global footprint in Malaysia by acquiring Firstline Pharmaceuticals Sdn. Bhd and Genomicks Sdn Bhd.
- Ambernath Manufacturing facility opens Animal Testing Facility and Quality Control Laboratory.
- Ground breaking of new manufacturing plant at Genome Valley, Telangana, India.
- Introduction of Adverse Event Reporting application : A pivotal stride in strengthening patient safety.
- Ambernath Manufacturing facility certified as PIC/s GMP Compliant by State Service of Ukraine on Medicines and Drugs Control.
